Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based superoxide dismutase mimic

2009 ◽  
Vol 7 (8) ◽  
pp. 931-939 ◽  
Author(s):  
William L. Ries ◽  
Lyndon L. Key ◽  
Ramona M. Rodriguiz
Blood ◽  
1973 ◽  
Vol 41 (6) ◽  
pp. 921-925 ◽  
Author(s):  
Philip Ashburn ◽  
M. Robert Cooper ◽  
Charles E. McCall ◽  
Lawrence R. DeChatelet

Abstract Quantitative and histochemical nitroblue tetrazolium reduction (NBT) tests were performed on leukocytes of 13 patients with polycythemia vera, seven with chronic granulocytic leukemia, eight with neoplastic disease associated with fever, 16 with bacterial infection, and 13 healthy control individuals. No significant differences were detected in the quantitative test between any of the groups studied. The histochemical NBT test was significantly higher than control in the patients with polycythemia vera and neoplasia associated with fever, as well as in those with known bacterial infection. It is suggested that patients with neoplasia or polycythemia vera may show a false positive reaction in the histochemical NBT test. Conversely, the test was significantly lower than control in patients with chronic granulocytic leukemia. Such patients might show a false negative reaction in the test even if infection were present.


1988 ◽  
Vol 34 (3) ◽  
pp. 497-500 ◽  
Author(s):  
Y Sun ◽  
L W Oberley ◽  
Y Li

Abstract This assay for superoxide dismutase (SOD, EC 1.15.1.1) activity involves inhibition of nitroblue tetrazolium reduction, with xanthine-xanthine oxidase used as a superoxide generator. By using a reaction terminator, we can determine 40 samples within 55 min. One unit of activity of pure bovine liver Cu,ZnSOD and chicken liver MnSOD was expressed by 30 ng and 500 ng of protein, respectively. The mean concentrations of Cu,ZnSOD as measured by this method in blood from normal adults were 242 (SEM 4) mg/L in erythrocytes, 548 (SEM 20) micrograms/L in serum, and 173 (SEM 11) micrograms/L in plasma. The Cu,ZnSOD concentrations in serum and plasma of patients with cancer of the large intestine tended to be less and greater than these values, respectively, but not statistically significantly so.


1989 ◽  
Vol 51 (3) ◽  
pp. 630-631
Author(s):  
Toshihiro WATARI ◽  
Ryo GOITSUKA ◽  
Hidekazu KOYAMA ◽  
Toshinori SAKO ◽  
Tomiya UCHINO ◽  
...  

1984 ◽  
Vol 98 (2) ◽  
pp. 391-398 ◽  
Author(s):  
D J Mangelsdorf ◽  
H P Koeffler ◽  
C A Donaldson ◽  
J W Pike ◽  
M R Haussler

The human-derived promyelocytic leukemia cell line, HL-60, is known to differentiate into mature myeloid cells in the presence of 1,25-dihydroxyvitamin D3 (1,25[OH]2D3). We investigated differentiation by monitoring 1,25(OH)2D3-exposed HL-60 cells for phagocytic activity, ability to reduce nitroblue tetrazolium, binding of the chemotaxin N-formyl-methionyl-leucyl-[3H]phenylalanine, development of nonspecific acid esterase activity, and morphological maturation of Wright-Giemsa-stained cells. 1,25(OH)2D3 concentrations as low as 10(-10) M caused significant development of phagocytosis, nitroblue tetrazolium reduction, and the emergence of differentiated myeloid cells that had morphological characteristics of both metamyelocytes and monocytes. These cells were conclusively identified as monocytes/macrophages based upon their adherence to the plastic flasks and their content of the macrophage-characteristic nonspecific acid esterase enzyme. The estimated ED50 for 1,25(OH)2D3-induced differentiation based upon nitroblue tetrazolium reduction and N-formyl-methionyl-leucyl-[3H]phenylalanine binding was 5.7 X 10(-9) M. HL-60 cells exhibited a complex growth response with various levels of 1,25(OH)2D3: less than or equal to 10(-10) M had no detectable effect, 10(-9) M stimulated growth, and greater than or equal to 10(-8) M sharply inhibited proliferation. We also detected and quantitated the specific receptor for 1,25(OH)2D3 in HL-60 and HL-60 Blast, a sub-clone resistant to the growth and differentiation effects of 1,25(OH)2D3. The receptor in both lines was characterized as a DNA-binding protein that migrated at 3.3S on high-salt sucrose gradients. Unequivocal identification was provided by selective dissociation of the 1,25(OH)2D3-receptor complex with the mercurial reagent, p-chloromercuribenzenesulfonic acid, and by a shift in its sedimentation position upon complexing with anti-receptor monoclonal antibody. On the basis of labeling of whole cells with 1,25(OH)2[3H]D3 in culture, we found that HL-60 contains approximately 4,000 1,25(OH)2D3 receptor molecules per cell, while the nonresponsive HL-60 Blast is endowed with approximately 8% of that number. The concentration of 1,25(OH)2D3 (5 X 10(-9) M) in complete culture medium, which facilitates the saturation of receptors in HL-60 cells, is virtually identical to the ED50 for the sterol's induction of differentiation. This correspondence, plus the resistance of the relatively receptor-poor HL-60 Blast, indicates that 1,25(OH)2D3-induced differentiation of HL-60 cells to monocytes/macrophages is occurring via receptor-mediated events.


Sign in / Sign up

Export Citation Format

Share Document